nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—PTGS1—Balsalazide—Crohn's disease	0.333	0.429	CbGbCtD
Hydromorphone—PTGS1—Mesalazine—Crohn's disease	0.266	0.343	CbGbCtD
Hydromorphone—PTGS1—Sulfasalazine—Crohn's disease	0.149	0.192	CbGbCtD
Hydromorphone—CYP3A4—Prednisone—Crohn's disease	0.0279	0.0359	CbGbCtD
Hydromorphone—Naloxone—TLR4—Crohn's disease	0.00404	0.889	CrCbGaD
Hydromorphone—Feeling hot—Mesalazine—Crohn's disease	0.0015	0.0084	CcSEcCtD
Hydromorphone—Withdrawal syndrome—Prednisone—Crohn's disease	0.00149	0.00836	CcSEcCtD
Hydromorphone—Intracranial pressure increased—Prednisone—Crohn's disease	0.00149	0.00836	CcSEcCtD
Hydromorphone—Rhinorrhoea—Mesalazine—Crohn's disease	0.00145	0.00814	CcSEcCtD
Hydromorphone—Cognitive disorder—Prednisone—Crohn's disease	0.00144	0.00807	CcSEcCtD
Hydromorphone—Breast disorder—Mercaptopurine—Crohn's disease	0.00142	0.00797	CcSEcCtD
Hydromorphone—Arthropathy—Mesalazine—Crohn's disease	0.0013	0.00725	CcSEcCtD
Hydromorphone—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.00127	0.00712	CcSEcCtD
Hydromorphone—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.00125	0.00697	CcSEcCtD
Hydromorphone—Stomatitis—Mercaptopurine—Crohn's disease	0.00118	0.00663	CcSEcCtD
Hydromorphone—Abnormal dreams—Mesalazine—Crohn's disease	0.00116	0.00652	CcSEcCtD
Hydromorphone—Eructation—Mesalazine—Crohn's disease	0.00116	0.00648	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00115	0.00643	CcSEcCtD
Hydromorphone—Dry eye—Mesalazine—Crohn's disease	0.00109	0.00609	CcSEcCtD
Hydromorphone—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00108	0.00606	CcSEcCtD
Hydromorphone—Coma—Mesalazine—Crohn's disease	0.00108	0.00603	CcSEcCtD
Hydromorphone—Ear pain—Mesalazine—Crohn's disease	0.001	0.00561	CcSEcCtD
Hydromorphone—Immune system disorder—Mercaptopurine—Crohn's disease	0.000984	0.00551	CcSEcCtD
Hydromorphone—Gastroenteritis—Mesalazine—Crohn's disease	0.000965	0.0054	CcSEcCtD
Hydromorphone—Disorientation—Mesalazine—Crohn's disease	0.000956	0.00535	CcSEcCtD
Hydromorphone—Malnutrition—Mercaptopurine—Crohn's disease	0.000949	0.00531	CcSEcCtD
Hydromorphone—Libido decreased—Mesalazine—Crohn's disease	0.000922	0.00516	CcSEcCtD
Hydromorphone—Increased appetite—Mesalazine—Crohn's disease	0.00091	0.0051	CcSEcCtD
Hydromorphone—Hepatomegaly—Prednisone—Crohn's disease	0.000881	0.00493	CcSEcCtD
Hydromorphone—Lethargy—Mesalazine—Crohn's disease	0.000873	0.00489	CcSEcCtD
Hydromorphone—Osteoarthritis—Mesalazine—Crohn's disease	0.000855	0.00479	CcSEcCtD
Hydromorphone—Leukopenia—Mercaptopurine—Crohn's disease	0.000849	0.00476	CcSEcCtD
Hydromorphone—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.000848	0.00475	CcSEcCtD
Hydromorphone—Affect lability—Mesalazine—Crohn's disease	0.000842	0.00471	CcSEcCtD
Hydromorphone—Migraine—Mesalazine—Crohn's disease	0.000842	0.00471	CcSEcCtD
Hydromorphone—Mood swings—Mesalazine—Crohn's disease	0.00081	0.00454	CcSEcCtD
Hydromorphone—Arthralgia—Mercaptopurine—Crohn's disease	0.000808	0.00452	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000802	0.00449	CcSEcCtD
Hydromorphone—Memory impairment—Prednisone—Crohn's disease	0.000794	0.00445	CcSEcCtD
Hydromorphone—Abdominal pain upper—Mesalazine—Crohn's disease	0.000781	0.00437	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000781	0.00437	CcSEcCtD
Hydromorphone—Breast disorder—Mesalazine—Crohn's disease	0.000773	0.00433	CcSEcCtD
Hydromorphone—Cramp muscle—Mesalazine—Crohn's disease	0.00077	0.00431	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00077	0.00431	CcSEcCtD
Hydromorphone—Nasopharyngitis—Mesalazine—Crohn's disease	0.000765	0.00428	CcSEcCtD
Hydromorphone—Gastritis—Mesalazine—Crohn's disease	0.000757	0.00424	CcSEcCtD
Hydromorphone—Skin disorder—Mercaptopurine—Crohn's disease	0.000752	0.00421	CcSEcCtD
Hydromorphone—Endocrine disorder—Prednisone—Crohn's disease	0.000752	0.00421	CcSEcCtD
Hydromorphone—Abdominal distension—Mesalazine—Crohn's disease	0.000744	0.00417	CcSEcCtD
Hydromorphone—Dysphagia—Mesalazine—Crohn's disease	0.000739	0.00414	CcSEcCtD
Hydromorphone—Asthma—Mesalazine—Crohn's disease	0.000739	0.00414	CcSEcCtD
Hydromorphone—Anorexia—Mercaptopurine—Crohn's disease	0.000738	0.00413	CcSEcCtD
Hydromorphone—Bronchospasm—Mesalazine—Crohn's disease	0.000727	0.00407	CcSEcCtD
Hydromorphone—Infestation—Azathioprine—Crohn's disease	0.000723	0.00405	CcSEcCtD
Hydromorphone—Infestation NOS—Azathioprine—Crohn's disease	0.000723	0.00405	CcSEcCtD
Hydromorphone—Contusion—Prednisone—Crohn's disease	0.000714	0.004	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000705	0.00395	CcSEcCtD
Hydromorphone—Dysuria—Mesalazine—Crohn's disease	0.000691	0.00387	CcSEcCtD
Hydromorphone—Arthropathy—Prednisone—Crohn's disease	0.000685	0.00384	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000684	0.00383	CcSEcCtD
Hydromorphone—Pollakiuria—Mesalazine—Crohn's disease	0.000683	0.00382	CcSEcCtD
Hydromorphone—Decreased appetite—Mercaptopurine—Crohn's disease	0.000673	0.00377	CcSEcCtD
Hydromorphone—Weight decreased—Mesalazine—Crohn's disease	0.000669	0.00374	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000669	0.00374	CcSEcCtD
Hydromorphone—Infestation NOS—Mesalazine—Crohn's disease	0.000659	0.00369	CcSEcCtD
Hydromorphone—Infestation—Mesalazine—Crohn's disease	0.000659	0.00369	CcSEcCtD
Hydromorphone—Depression—Mesalazine—Crohn's disease	0.000657	0.00368	CcSEcCtD
Hydromorphone—Stomatitis—Mesalazine—Crohn's disease	0.000642	0.0036	CcSEcCtD
Hydromorphone—Sweating—Mesalazine—Crohn's disease	0.000632	0.00354	CcSEcCtD
Hydromorphone—Hiccups—Prednisone—Crohn's disease	0.000623	0.00349	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000623	0.00349	CcSEcCtD
Hydromorphone—Body temperature increased—Mercaptopurine—Crohn's disease	0.000612	0.00343	CcSEcCtD
Hydromorphone—Rhinitis—Mesalazine—Crohn's disease	0.000593	0.00332	CcSEcCtD
Hydromorphone—Fluid retention—Prednisone—Crohn's disease	0.000592	0.00331	CcSEcCtD
Hydromorphone—Immune system disorder—Azathioprine—Crohn's disease	0.000587	0.00328	CcSEcCtD
Hydromorphone—Mediastinal disorder—Azathioprine—Crohn's disease	0.000585	0.00328	CcSEcCtD
Hydromorphone—Urinary tract disorder—Mesalazine—Crohn's disease	0.000584	0.00327	CcSEcCtD
Hydromorphone—Oedema peripheral—Mesalazine—Crohn's disease	0.000583	0.00326	CcSEcCtD
Hydromorphone—Chills—Azathioprine—Crohn's disease	0.000583	0.00326	CcSEcCtD
Hydromorphone—Connective tissue disorder—Mesalazine—Crohn's disease	0.000581	0.00326	CcSEcCtD
Hydromorphone—Arrhythmia—Azathioprine—Crohn's disease	0.00058	0.00325	CcSEcCtD
Hydromorphone—Urethral disorder—Mesalazine—Crohn's disease	0.00058	0.00325	CcSEcCtD
Hydromorphone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00057	0.00319	CcSEcCtD
Hydromorphone—Pulmonary oedema—Prednisone—Crohn's disease	0.000555	0.00311	CcSEcCtD
Hydromorphone—Eye disorder—Mesalazine—Crohn's disease	0.000553	0.0031	CcSEcCtD
Hydromorphone—Tinnitus—Mesalazine—Crohn's disease	0.000552	0.00309	CcSEcCtD
Hydromorphone—Cardiac disorder—Mesalazine—Crohn's disease	0.000549	0.00307	CcSEcCtD
Hydromorphone—Angiopathy—Mesalazine—Crohn's disease	0.000537	0.00301	CcSEcCtD
Hydromorphone—Euphoric mood—Prednisone—Crohn's disease	0.000535	0.003	CcSEcCtD
Hydromorphone—Immune system disorder—Mesalazine—Crohn's disease	0.000534	0.00299	CcSEcCtD
Hydromorphone—Mediastinal disorder—Mesalazine—Crohn's disease	0.000533	0.00299	CcSEcCtD
Hydromorphone—Chills—Mesalazine—Crohn's disease	0.000531	0.00297	CcSEcCtD
Hydromorphone—Diarrhoea—Mercaptopurine—Crohn's disease	0.00053	0.00297	CcSEcCtD
Hydromorphone—Ill-defined disorder—Azathioprine—Crohn's disease	0.000525	0.00294	CcSEcCtD
Hydromorphone—Mental disorder—Mesalazine—Crohn's disease	0.000518	0.0029	CcSEcCtD
Hydromorphone—Erythema—Mesalazine—Crohn's disease	0.000515	0.00288	CcSEcCtD
Hydromorphone—Malaise—Azathioprine—Crohn's disease	0.00051	0.00285	CcSEcCtD
Hydromorphone—Flatulence—Mesalazine—Crohn's disease	0.000507	0.00284	CcSEcCtD
Hydromorphone—Leukopenia—Azathioprine—Crohn's disease	0.000506	0.00283	CcSEcCtD
Hydromorphone—Tension—Mesalazine—Crohn's disease	0.000505	0.00283	CcSEcCtD
Hydromorphone—Dysgeusia—Mesalazine—Crohn's disease	0.000504	0.00282	CcSEcCtD
Hydromorphone—Naloxone—ALB—Crohn's disease	0.000504	0.111	CrCbGaD
Hydromorphone—Nervousness—Mesalazine—Crohn's disease	0.0005	0.0028	CcSEcCtD
Hydromorphone—Back pain—Mesalazine—Crohn's disease	0.000498	0.00279	CcSEcCtD
Hydromorphone—Muscle spasms—Mesalazine—Crohn's disease	0.000495	0.00277	CcSEcCtD
Hydromorphone—Vomiting—Mercaptopurine—Crohn's disease	0.000492	0.00276	CcSEcCtD
Hydromorphone—Injury—Prednisone—Crohn's disease	0.000492	0.00276	CcSEcCtD
Hydromorphone—Rash—Mercaptopurine—Crohn's disease	0.000488	0.00273	CcSEcCtD
Hydromorphone—Dermatitis—Mercaptopurine—Crohn's disease	0.000488	0.00273	CcSEcCtD
Hydromorphone—Vision blurred—Mesalazine—Crohn's disease	0.000485	0.00272	CcSEcCtD
Hydromorphone—Tremor—Mesalazine—Crohn's disease	0.000482	0.0027	CcSEcCtD
Hydromorphone—Amnesia—Prednisone—Crohn's disease	0.000482	0.0027	CcSEcCtD
Hydromorphone—Increased appetite—Prednisone—Crohn's disease	0.000482	0.0027	CcSEcCtD
Hydromorphone—Arthralgia—Azathioprine—Crohn's disease	0.000481	0.0027	CcSEcCtD
Hydromorphone—Myalgia—Azathioprine—Crohn's disease	0.000481	0.0027	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000478	0.00268	CcSEcCtD
Hydromorphone—Ill-defined disorder—Mesalazine—Crohn's disease	0.000478	0.00268	CcSEcCtD
Hydromorphone—Discomfort—Azathioprine—Crohn's disease	0.000476	0.00266	CcSEcCtD
Hydromorphone—Angioedema—Mesalazine—Crohn's disease	0.000471	0.00264	CcSEcCtD
Hydromorphone—Malaise—Mesalazine—Crohn's disease	0.000464	0.0026	CcSEcCtD
Hydromorphone—Vertigo—Mesalazine—Crohn's disease	0.000463	0.00259	CcSEcCtD
Hydromorphone—Syncope—Mesalazine—Crohn's disease	0.000462	0.00259	CcSEcCtD
Hydromorphone—Lethargy—Prednisone—Crohn's disease	0.000462	0.00259	CcSEcCtD
Hydromorphone—Leukopenia—Mesalazine—Crohn's disease	0.000461	0.00258	CcSEcCtD
Hydromorphone—Nausea—Mercaptopurine—Crohn's disease	0.00046	0.00258	CcSEcCtD
Hydromorphone—Infection—Azathioprine—Crohn's disease	0.000458	0.00257	CcSEcCtD
Hydromorphone—Palpitations—Mesalazine—Crohn's disease	0.000455	0.00255	CcSEcCtD
Hydromorphone—Loss of consciousness—Mesalazine—Crohn's disease	0.000453	0.00253	CcSEcCtD
Hydromorphone—Osteoarthritis—Prednisone—Crohn's disease	0.000452	0.00253	CcSEcCtD
Hydromorphone—Cough—Mesalazine—Crohn's disease	0.000449	0.00252	CcSEcCtD
Hydromorphone—Skin disorder—Azathioprine—Crohn's disease	0.000448	0.00251	CcSEcCtD
Hydromorphone—Affect lability—Prednisone—Crohn's disease	0.000445	0.00249	CcSEcCtD
Hydromorphone—Hypertension—Mesalazine—Crohn's disease	0.000445	0.00249	CcSEcCtD
Hydromorphone—Psychotic disorder—Prednisone—Crohn's disease	0.000442	0.00247	CcSEcCtD
Hydromorphone—Arthralgia—Mesalazine—Crohn's disease	0.000438	0.00246	CcSEcCtD
Hydromorphone—Chest pain—Mesalazine—Crohn's disease	0.000438	0.00246	CcSEcCtD
Hydromorphone—Myalgia—Mesalazine—Crohn's disease	0.000438	0.00246	CcSEcCtD
Hydromorphone—Anxiety—Mesalazine—Crohn's disease	0.000437	0.00245	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000435	0.00244	CcSEcCtD
Hydromorphone—Discomfort—Mesalazine—Crohn's disease	0.000433	0.00243	CcSEcCtD
Hydromorphone—Hypotension—Azathioprine—Crohn's disease	0.000431	0.00241	CcSEcCtD
Hydromorphone—Cardiac arrest—Prednisone—Crohn's disease	0.00043	0.00241	CcSEcCtD
Hydromorphone—Dry mouth—Mesalazine—Crohn's disease	0.000429	0.0024	CcSEcCtD
Hydromorphone—Mood swings—Prednisone—Crohn's disease	0.000429	0.0024	CcSEcCtD
Hydromorphone—Confusional state—Mesalazine—Crohn's disease	0.000424	0.00237	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00042	0.00235	CcSEcCtD
Hydromorphone—Anaphylactic shock—Mesalazine—Crohn's disease	0.00042	0.00235	CcSEcCtD
Hydromorphone—Infection—Mesalazine—Crohn's disease	0.000418	0.00234	CcSEcCtD
Hydromorphone—Shock—Mesalazine—Crohn's disease	0.000413	0.00232	CcSEcCtD
Hydromorphone—Nervous system disorder—Mesalazine—Crohn's disease	0.000412	0.00231	CcSEcCtD
Hydromorphone—Tachycardia—Mesalazine—Crohn's disease	0.00041	0.0023	CcSEcCtD
Hydromorphone—Skin disorder—Mesalazine—Crohn's disease	0.000408	0.00229	CcSEcCtD
Hydromorphone—Hyperhidrosis—Mesalazine—Crohn's disease	0.000406	0.00228	CcSEcCtD
Hydromorphone—Anorexia—Mesalazine—Crohn's disease	0.000401	0.00224	CcSEcCtD
Hydromorphone—Muscular weakness—Prednisone—Crohn's disease	0.000399	0.00223	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000398	0.00223	CcSEcCtD
Hydromorphone—Abdominal distension—Prednisone—Crohn's disease	0.000394	0.0022	CcSEcCtD
Hydromorphone—Hypotension—Mesalazine—Crohn's disease	0.000393	0.0022	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000383	0.00214	CcSEcCtD
Hydromorphone—Sweating increased—Prednisone—Crohn's disease	0.000381	0.00213	CcSEcCtD
Hydromorphone—Feeling abnormal—Azathioprine—Crohn's disease	0.00038	0.00213	CcSEcCtD
Hydromorphone—Insomnia—Mesalazine—Crohn's disease	0.00038	0.00213	CcSEcCtD
Hydromorphone—Paraesthesia—Mesalazine—Crohn's disease	0.000377	0.00211	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000377	0.00211	CcSEcCtD
Hydromorphone—Dyspnoea—Mesalazine—Crohn's disease	0.000375	0.0021	CcSEcCtD
Hydromorphone—Somnolence—Mesalazine—Crohn's disease	0.000374	0.00209	CcSEcCtD
Hydromorphone—Dyspepsia—Mesalazine—Crohn's disease	0.00037	0.00207	CcSEcCtD
Hydromorphone—Decreased appetite—Mesalazine—Crohn's disease	0.000365	0.00205	CcSEcCtD
Hydromorphone—Body temperature increased—Azathioprine—Crohn's disease	0.000365	0.00204	CcSEcCtD
Hydromorphone—Abdominal pain—Azathioprine—Crohn's disease	0.000365	0.00204	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000363	0.00203	CcSEcCtD
Hydromorphone—Fatigue—Mesalazine—Crohn's disease	0.000362	0.00203	CcSEcCtD
Hydromorphone—Erectile dysfunction—Prednisone—Crohn's disease	0.00036	0.00202	CcSEcCtD
Hydromorphone—Pain—Mesalazine—Crohn's disease	0.000359	0.00201	CcSEcCtD
Hydromorphone—Constipation—Mesalazine—Crohn's disease	0.000359	0.00201	CcSEcCtD
Hydromorphone—Weight decreased—Prednisone—Crohn's disease	0.000354	0.00198	CcSEcCtD
Hydromorphone—Depression—Prednisone—Crohn's disease	0.000348	0.00195	CcSEcCtD
Hydromorphone—Feeling abnormal—Mesalazine—Crohn's disease	0.000346	0.00194	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000344	0.00192	CcSEcCtD
Hydromorphone—Hypersensitivity—Azathioprine—Crohn's disease	0.00034	0.0019	CcSEcCtD
Hydromorphone—Urticaria—Mesalazine—Crohn's disease	0.000334	0.00187	CcSEcCtD
Hydromorphone—Abdominal pain—Mesalazine—Crohn's disease	0.000332	0.00186	CcSEcCtD
Hydromorphone—Body temperature increased—Mesalazine—Crohn's disease	0.000332	0.00186	CcSEcCtD
Hydromorphone—Bradycardia—Prednisone—Crohn's disease	0.000319	0.00178	CcSEcCtD
Hydromorphone—Diarrhoea—Azathioprine—Crohn's disease	0.000316	0.00177	CcSEcCtD
Hydromorphone—Hallucination—Prednisone—Crohn's disease	0.000311	0.00174	CcSEcCtD
Hydromorphone—Hypersensitivity—Mesalazine—Crohn's disease	0.00031	0.00173	CcSEcCtD
Hydromorphone—Connective tissue disorder—Prednisone—Crohn's disease	0.000308	0.00172	CcSEcCtD
Hydromorphone—Dizziness—Azathioprine—Crohn's disease	0.000305	0.00171	CcSEcCtD
Hydromorphone—Asthenia—Mesalazine—Crohn's disease	0.000302	0.00169	CcSEcCtD
Hydromorphone—Pruritus—Mesalazine—Crohn's disease	0.000297	0.00167	CcSEcCtD
Hydromorphone—Vomiting—Azathioprine—Crohn's disease	0.000293	0.00164	CcSEcCtD
Hydromorphone—Eye disorder—Prednisone—Crohn's disease	0.000292	0.00164	CcSEcCtD
Hydromorphone—Rash—Azathioprine—Crohn's disease	0.000291	0.00163	CcSEcCtD
Hydromorphone—Dermatitis—Azathioprine—Crohn's disease	0.000291	0.00163	CcSEcCtD
Hydromorphone—Flushing—Prednisone—Crohn's disease	0.00029	0.00163	CcSEcCtD
Hydromorphone—Headache—Azathioprine—Crohn's disease	0.000289	0.00162	CcSEcCtD
Hydromorphone—Diarrhoea—Mesalazine—Crohn's disease	0.000288	0.00161	CcSEcCtD
Hydromorphone—Angiopathy—Prednisone—Crohn's disease	0.000284	0.00159	CcSEcCtD
Hydromorphone—Immune system disorder—Prednisone—Crohn's disease	0.000283	0.00158	CcSEcCtD
Hydromorphone—Arrhythmia—Prednisone—Crohn's disease	0.00028	0.00157	CcSEcCtD
Hydromorphone—Dizziness—Mesalazine—Crohn's disease	0.000278	0.00156	CcSEcCtD
Hydromorphone—Mental disorder—Prednisone—Crohn's disease	0.000274	0.00154	CcSEcCtD
Hydromorphone—Nausea—Azathioprine—Crohn's disease	0.000274	0.00153	CcSEcCtD
Hydromorphone—Erythema—Prednisone—Crohn's disease	0.000272	0.00153	CcSEcCtD
Hydromorphone—Malnutrition—Prednisone—Crohn's disease	0.000272	0.00153	CcSEcCtD
Hydromorphone—Vomiting—Mesalazine—Crohn's disease	0.000267	0.0015	CcSEcCtD
Hydromorphone—Rash—Mesalazine—Crohn's disease	0.000265	0.00148	CcSEcCtD
Hydromorphone—Dermatitis—Mesalazine—Crohn's disease	0.000265	0.00148	CcSEcCtD
Hydromorphone—Headache—Mesalazine—Crohn's disease	0.000263	0.00147	CcSEcCtD
Hydromorphone—Vision blurred—Prednisone—Crohn's disease	0.000257	0.00144	CcSEcCtD
Hydromorphone—Ill-defined disorder—Prednisone—Crohn's disease	0.000253	0.00142	CcSEcCtD
Hydromorphone—Agitation—Prednisone—Crohn's disease	0.00025	0.0014	CcSEcCtD
Hydromorphone—Nausea—Mesalazine—Crohn's disease	0.00025	0.0014	CcSEcCtD
Hydromorphone—Angioedema—Prednisone—Crohn's disease	0.000249	0.00139	CcSEcCtD
Hydromorphone—Malaise—Prednisone—Crohn's disease	0.000246	0.00138	CcSEcCtD
Hydromorphone—Vertigo—Prednisone—Crohn's disease	0.000245	0.00137	CcSEcCtD
Hydromorphone—Syncope—Prednisone—Crohn's disease	0.000244	0.00137	CcSEcCtD
Hydromorphone—Loss of consciousness—Prednisone—Crohn's disease	0.000239	0.00134	CcSEcCtD
Hydromorphone—Convulsion—Prednisone—Crohn's disease	0.000236	0.00132	CcSEcCtD
Hydromorphone—Hypertension—Prednisone—Crohn's disease	0.000235	0.00132	CcSEcCtD
Hydromorphone—Myalgia—Prednisone—Crohn's disease	0.000232	0.0013	CcSEcCtD
Hydromorphone—Arthralgia—Prednisone—Crohn's disease	0.000232	0.0013	CcSEcCtD
Hydromorphone—Anxiety—Prednisone—Crohn's disease	0.000231	0.00129	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00023	0.00129	CcSEcCtD
Hydromorphone—Discomfort—Prednisone—Crohn's disease	0.000229	0.00128	CcSEcCtD
Hydromorphone—Anaphylactic shock—Prednisone—Crohn's disease	0.000222	0.00125	CcSEcCtD
Hydromorphone—Infection—Prednisone—Crohn's disease	0.000221	0.00124	CcSEcCtD
Hydromorphone—Shock—Prednisone—Crohn's disease	0.000219	0.00123	CcSEcCtD
Hydromorphone—Nervous system disorder—Prednisone—Crohn's disease	0.000218	0.00122	CcSEcCtD
Hydromorphone—Tachycardia—Prednisone—Crohn's disease	0.000217	0.00122	CcSEcCtD
Hydromorphone—Skin disorder—Prednisone—Crohn's disease	0.000216	0.00121	CcSEcCtD
Hydromorphone—Hyperhidrosis—Prednisone—Crohn's disease	0.000215	0.0012	CcSEcCtD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000212	0.00525	CbGpPWpGaD
Hydromorphone—Anorexia—Prednisone—Crohn's disease	0.000212	0.00119	CcSEcCtD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000204	0.00505	CbGpPWpGaD
Hydromorphone—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000203	0.00113	CcSEcCtD
Hydromorphone—OPRD1—GPCR ligand binding—CCR9—Crohn's disease	0.000201	0.00498	CbGpPWpGaD
Hydromorphone—Insomnia—Prednisone—Crohn's disease	0.000201	0.00113	CcSEcCtD
Hydromorphone—Paraesthesia—Prednisone—Crohn's disease	0.0002	0.00112	CcSEcCtD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000196	0.00484	CbGpPWpGaD
Hydromorphone—Dyspepsia—Prednisone—Crohn's disease	0.000196	0.0011	CcSEcCtD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.000193	0.00478	CbGpPWpGaD
Hydromorphone—Decreased appetite—Prednisone—Crohn's disease	0.000193	0.00108	CcSEcCtD
Hydromorphone—OPRK1—G alpha (i) signalling events—CCR6—Crohn's disease	0.000193	0.00477	CbGpPWpGaD
Hydromorphone—Fatigue—Prednisone—Crohn's disease	0.000192	0.00107	CcSEcCtD
Hydromorphone—Constipation—Prednisone—Crohn's disease	0.00019	0.00106	CcSEcCtD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.00019	0.0047	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—GPR65—Crohn's disease	0.000187	0.00463	CbGpPWpGaD
Hydromorphone—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	0.000184	0.00455	CbGpPWpGaD
Hydromorphone—Feeling abnormal—Prednisone—Crohn's disease	0.000183	0.00103	CcSEcCtD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000182	0.0045	CbGpPWpGaD
Hydromorphone—Gastrointestinal pain—Prednisone—Crohn's disease	0.000182	0.00102	CcSEcCtD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00018	0.00445	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000179	0.00443	CbGpPWpGaD
Hydromorphone—Urticaria—Prednisone—Crohn's disease	0.000177	0.000989	CcSEcCtD
Hydromorphone—OPRK1—GPCR ligand binding—CCR9—Crohn's disease	0.000176	0.00436	CbGpPWpGaD
Hydromorphone—Body temperature increased—Prednisone—Crohn's disease	0.000176	0.000984	CcSEcCtD
Hydromorphone—Abdominal pain—Prednisone—Crohn's disease	0.000176	0.000984	CcSEcCtD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000175	0.00433	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—JAK2—Crohn's disease	0.000167	0.00414	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—MLN—Crohn's disease	0.000164	0.00406	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—GPR65—Crohn's disease	0.000164	0.00406	CbGpPWpGaD
Hydromorphone—Hypersensitivity—Prednisone—Crohn's disease	0.000164	0.000917	CcSEcCtD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000164	0.00405	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—CCR6—Crohn's disease	0.000163	0.00403	CbGpPWpGaD
Hydromorphone—Asthenia—Prednisone—Crohn's disease	0.00016	0.000893	CcSEcCtD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000158	0.0039	CbGpPWpGaD
Hydromorphone—Pruritus—Prednisone—Crohn's disease	0.000157	0.000881	CcSEcCtD
Hydromorphone—OPRD1—Signaling by GPCR—ACKR2—Crohn's disease	0.000157	0.00389	CbGpPWpGaD
Hydromorphone—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000156	0.00385	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000154	0.00381	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000153	0.00379	CbGpPWpGaD
Hydromorphone—Diarrhoea—Prednisone—Crohn's disease	0.000152	0.000852	CcSEcCtD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000151	0.00374	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CCR9—Crohn's disease	0.000149	0.00369	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—MLN—Crohn's disease	0.000149	0.00368	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	0.000148	0.00366	CbGpPWpGaD
Hydromorphone—Dizziness—Prednisone—Crohn's disease	0.000147	0.000823	CcSEcCtD
Hydromorphone—OPRK1—GPCR downstream signaling—MLN—Crohn's disease	0.000144	0.00356	CbGpPWpGaD
Hydromorphone—Vomiting—Prednisone—Crohn's disease	0.000141	0.000792	CcSEcCtD
Hydromorphone—Rash—Prednisone—Crohn's disease	0.00014	0.000785	CcSEcCtD
Hydromorphone—Dermatitis—Prednisone—Crohn's disease	0.00014	0.000784	CcSEcCtD
Hydromorphone—Headache—Prednisone—Crohn's disease	0.000139	0.00078	CcSEcCtD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000139	0.00344	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—GPR65—Crohn's disease	0.000139	0.00343	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000138	0.00341	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—ACKR2—Crohn's disease	0.000138	0.00341	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.000136	0.00336	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000135	0.00334	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000133	0.0033	CbGpPWpGaD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000133	0.0033	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CCR6—Crohn's disease	0.000133	0.0033	CbGpPWpGaD
Hydromorphone—Nausea—Prednisone—Crohn's disease	0.000132	0.00074	CcSEcCtD
Hydromorphone—OPRK1—Signaling by GPCR—MLN—Crohn's disease	0.000131	0.00323	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00013	0.00321	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—MLN—Crohn's disease	0.000122	0.00301	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—CD4—Crohn's disease	0.000118	0.00291	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—PTGER4—Crohn's disease	0.000117	0.0029	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CCR6—Crohn's disease	0.000117	0.00289	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.000116	0.00288	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000114	0.00282	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CCR9—Crohn's disease	0.000114	0.00281	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000114	0.00281	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	0.000113	0.0028	CbGpPWpGaD
Hydromorphone—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000113	0.00279	CbGpPWpGaD
Hydromorphone—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	0.000112	0.00277	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—MLN—Crohn's disease	0.00011	0.00273	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—IL1B—Crohn's disease	0.000109	0.00269	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000108	0.00268	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—GPR65—Crohn's disease	0.000106	0.00261	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	0.000103	0.00256	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CCR9—Crohn's disease	0.000103	0.00255	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—PTGER4—Crohn's disease	0.000103	0.00254	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000102	0.00251	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CCR9—Crohn's disease	9.97e-05	0.00247	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	9.91e-05	0.00245	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	9.87e-05	0.00244	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—GPR65—Crohn's disease	9.6e-05	0.00237	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ACKR2—Crohn's disease	9.28e-05	0.0023	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—GPR65—Crohn's disease	9.27e-05	0.00229	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	9.22e-05	0.00228	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CCR9—Crohn's disease	9.05e-05	0.00224	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.84e-05	0.00219	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MLN—Crohn's disease	8.8e-05	0.00218	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	8.69e-05	0.00215	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	8.42e-05	0.00208	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—GPR65—Crohn's disease	8.41e-05	0.00208	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	8.41e-05	0.00208	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.28e-05	0.00205	CbGpPWpGaD
Hydromorphone—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	8.19e-05	0.00203	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ACKR2—Crohn's disease	8.14e-05	0.00201	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TAGAP—Crohn's disease	8.05e-05	0.00199	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	7.83e-05	0.00194	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MLN—Crohn's disease	7.71e-05	0.00191	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	7.65e-05	0.00189	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CCR6—Crohn's disease	7.53e-05	0.00186	CbGpPWpGaD
Hydromorphone—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	7.37e-05	0.00182	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	7.37e-05	0.00182	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PLA2G4F—Crohn's disease	7.29e-05	0.0018	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	7.11e-05	0.00176	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	7.09e-05	0.00175	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	7.06e-05	0.00175	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	7.03e-05	0.00174	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	7.02e-05	0.00174	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	6.88e-05	0.0017	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	6.84e-05	0.00169	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	6.69e-05	0.00166	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	6.67e-05	0.00165	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	6.63e-05	0.00164	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	6.6e-05	0.00163	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MLN—Crohn's disease	6.52e-05	0.00161	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	6.36e-05	0.00157	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	6.23e-05	0.00154	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	6.22e-05	0.00154	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—MTMR3—Crohn's disease	6.2e-05	0.00153	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	6.17e-05	0.00153	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCR9—Crohn's disease	6.1e-05	0.00151	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	6.02e-05	0.00149	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	6e-05	0.00148	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.97e-05	0.00148	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	5.96e-05	0.00147	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PLA2G4F—Crohn's disease	5.94e-05	0.00147	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	5.85e-05	0.00145	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	5.81e-05	0.00144	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—GPR65—Crohn's disease	5.67e-05	0.0014	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	5.65e-05	0.0014	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	5.64e-05	0.00139	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	5.58e-05	0.00138	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	5.46e-05	0.00135	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	5.4e-05	0.00134	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCR9—Crohn's disease	5.35e-05	0.00132	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	5.28e-05	0.00131	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	5.26e-05	0.0013	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	5.21e-05	0.00129	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL3—Crohn's disease	5.13e-05	0.00127	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	5.07e-05	0.00125	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—MTMR3—Crohn's disease	5.05e-05	0.00125	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GPR65—Crohn's disease	4.97e-05	0.00123	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	4.96e-05	0.00123	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	4.95e-05	0.00122	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	4.94e-05	0.00122	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	4.94e-05	0.00122	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	4.91e-05	0.00122	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—FADS1—Crohn's disease	4.83e-05	0.00119	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	4.79e-05	0.00118	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.65e-05	0.00115	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GPX4—Crohn's disease	4.52e-05	0.00112	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCR9—Crohn's disease	4.52e-05	0.00112	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL3—Crohn's disease	4.5e-05	0.00111	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	4.46e-05	0.0011	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GCKR—Crohn's disease	4.37e-05	0.00108	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.35e-05	0.00108	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	4.35e-05	0.00108	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	4.29e-05	0.00106	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GPR65—Crohn's disease	4.2e-05	0.00104	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	4.18e-05	0.00104	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	4.18e-05	0.00103	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	4.05e-05	0.001	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCR6—Crohn's disease	4.04e-05	0.000999	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	3.96e-05	0.000978	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—FADS1—Crohn's disease	3.94e-05	0.000974	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL3—Crohn's disease	3.8e-05	0.00094	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	3.76e-05	0.000931	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GPX4—Crohn's disease	3.69e-05	0.000912	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	3.68e-05	0.000909	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RBX1—Crohn's disease	3.65e-05	0.000904	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	3.59e-05	0.000888	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GCKR—Crohn's disease	3.56e-05	0.000881	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	3.56e-05	0.00088	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCR6—Crohn's disease	3.54e-05	0.000876	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	3.47e-05	0.000858	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	3.2e-05	0.000792	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RBX1—Crohn's disease	3.2e-05	0.000792	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	3.18e-05	0.000787	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	3.15e-05	0.00078	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	3.15e-05	0.000779	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	3.13e-05	0.000773	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.12e-05	0.000772	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	3.12e-05	0.000771	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	3.11e-05	0.000768	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL3—Crohn's disease	3.03e-05	0.000749	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCR6—Crohn's disease	2.99e-05	0.00074	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	2.93e-05	0.000725	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	2.93e-05	0.000725	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	2.81e-05	0.000695	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.73e-05	0.000676	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	2.72e-05	0.000674	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RBX1—Crohn's disease	2.71e-05	0.00067	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—MTMR3—Crohn's disease	2.68e-05	0.000663	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	2.66e-05	0.000658	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	2.66e-05	0.000658	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—MTMR3—Crohn's disease	2.66e-05	0.000657	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL3—Crohn's disease	2.66e-05	0.000657	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	2.65e-05	0.000657	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	2.64e-05	0.000652	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	2.57e-05	0.000635	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.55e-05	0.00063	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	2.53e-05	0.000626	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	2.43e-05	0.0006	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	2.41e-05	0.000597	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	2.37e-05	0.000587	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	2.33e-05	0.000577	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	2.33e-05	0.000576	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	2.3e-05	0.000569	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	2.29e-05	0.000567	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL3—Crohn's disease	2.24e-05	0.000555	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.23e-05	0.000551	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	2.22e-05	0.000549	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	2.2e-05	0.000545	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	2.17e-05	0.000537	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	2.13e-05	0.000526	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	2.12e-05	0.000525	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	2.12e-05	0.000524	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—FADS1—Crohn's disease	2.09e-05	0.000517	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—FADS1—Crohn's disease	2.07e-05	0.000512	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.06e-05	0.00051	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	2.01e-05	0.000497	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	1.97e-05	0.000487	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	1.97e-05	0.000487	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GPX4—Crohn's disease	1.96e-05	0.000484	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GPX4—Crohn's disease	1.94e-05	0.000479	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	1.93e-05	0.000478	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GCKR—Crohn's disease	1.89e-05	0.000467	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	1.88e-05	0.000464	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GCKR—Crohn's disease	1.87e-05	0.000463	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	1.86e-05	0.00046	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	1.8e-05	0.000445	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	1.79e-05	0.000443	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.75e-05	0.000433	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	1.7e-05	0.00042	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	1.63e-05	0.000404	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	1.57e-05	0.000389	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TYK2—Crohn's disease	1.49e-05	0.00037	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—JAK2—Crohn's disease	1.43e-05	0.000353	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALB—Crohn's disease	1.39e-05	0.000344	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—FADS1—Crohn's disease	1.37e-05	0.000338	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.34e-05	0.000331	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TYK2—Crohn's disease	1.31e-05	0.000324	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	1.3e-05	0.000322	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX4—Crohn's disease	1.28e-05	0.000316	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—JAK2—Crohn's disease	1.25e-05	0.000309	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL6—Crohn's disease	1.24e-05	0.000306	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GCKR—Crohn's disease	1.23e-05	0.000305	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—Crohn's disease	1.22e-05	0.000301	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.17e-05	0.00029	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	1.14e-05	0.000282	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—Crohn's disease	1.13e-05	0.00028	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TYK2—Crohn's disease	1.11e-05	0.000274	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL6—Crohn's disease	1.09e-05	0.000268	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—JAK2—Crohn's disease	1.06e-05	0.000261	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—STAT3—Crohn's disease	1.05e-05	0.000259	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—Crohn's disease	9.92e-06	0.000245	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	9.65e-06	0.000239	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—STAT3—Crohn's disease	9.18e-06	0.000227	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6—Crohn's disease	9.17e-06	0.000227	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—STAT3—Crohn's disease	7.76e-06	0.000192	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6—Crohn's disease	7.31e-06	0.000181	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6—Crohn's disease	6.41e-06	0.000159	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—Crohn's disease	6.01e-06	0.000149	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—Crohn's disease	5.96e-06	0.000147	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6—Crohn's disease	5.42e-06	0.000134	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—Crohn's disease	5.26e-06	0.00013	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—Crohn's disease	5.21e-06	0.000129	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—Crohn's disease	3.93e-06	9.72e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.44e-06	8.5e-05	CbGpPWpGaD
